search

Stevanato Group SpA (STVN)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Stevanato: Q3 Earnings Snapshot
Nov 3, 2026

Stevanato: Q3 Earnings Snapshot

Stevanato Group SpA reported strong third-quarter earnings of $48.1 million, or 17 cents per share, surpassing Wall Street expectations. Adjusted earnings were 18 cents per share, exceeding the average analyst estimate of 17 cents. The company, a maker of glass vials for vaccines, posted revenue of $375.3 million and provided full-year earnings guidance between 69 and 71 cents per share with revenue in the range of $1.45 billion to $1.47 billion.
Company relevance
100.00%
Company sentiment
Bullish
Overall sentiment
Bullish
Stevanato Group S.p.A. $STVN Stock Acquired by Schwartz Investment Counsel Inc.
Oct 28, 2026

Stevanato Group S.p.A. $STVN Stock Acquired by Schwartz Investment Counsel Inc.

Schwartz Investment Counsel Inc. significantly increased its stake in Stevanato Group S.p.A. (NYSE:STVN) during the third quarter of 2026, adding 86,385 shares to own a total of 661,136 shares valued at $13.9 million. This move aligns with several other institutional investors who have expanded or initiated positions in the company. Despite reporting slightly below-consensus quarterly EPS, analysts maintain a "Moderate Buy" rating for Stevanato Group, with projected full-year EPS of €0.69.
Company relevance
100.00%
Company sentiment
Neutral
Overall sentiment
Neutral